Drug resistant breast cancer cells overexpress ETS1 gene

Date

2010-09-01

Author

Kars, Meltem Demirel
Iseri, Ozlem Darcansoy
Gündüz, Ufuk

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

138
views

0
downloads

Purpose. - Multidrug resistance (MDR) is resistance to wide range of structurally unrelated anticancer agents. MDR is a serious limitation to the effective chemotherapy. Involvement of ETS1 overexpression in upregulation of MDR1 gene expression is implicated. In the present study the aim was to assess the involvement of ETS1 and the genes, which encode the proteins interacting with ETS1 in drug resistant MCF-7 breast cancer cells.

Subject Keywords

ETS1, MCF-7, MDR1, Matrix metalloproteinases, Microarray analysis

URI

https://hdl.handle.net/11511/30079

Journal

BIOMEDICINE & PHARMACOTHERAPY

DOI

https://doi.org/10.1016/j.biopha.2010.01.008

Collections

Graduate School of Natural and Applied Sciences, Article

Suggestions

OpenMETU
Core

Bioreduction of Idarubicin and Formation of ROS Responsible for DNA Cleavage by NADPH-Cytochrome P450 Reductase and its Potential Role in the Antitumor Effect Celik, Haydar; Arinc, Emel (2008-01-01) Purpose. Idarubicin is a clinically effective synthetic anthracycline analog used in the treatment of several human neoplasms. Anthracyclines have the potential to undergo bioactivation by flavoenzymes to free radicals and thus exert their cytotoxic actions. In this study, our main objective was to investigate the possible involvement of NADPH-cytochrome P450 reductase in the bioreductive activation of idarubicin to DNA-damaging species. Methods. A pBR322 plasmid DNA damage assay was used as a sensitive met...
Numerical Simulation of the Storm Surge at the Sakhalin Island Southern Part on November 15, 2019 Zaytsev, A.; Pelinovsky, E. N.; Dogan, D.; Yalciner, B.; Yalçıner, Ahmet Cevdet; Kurkin, A. A.; Moskvitin, A. A. (2020-01-01) Purpose. Investigation of the storm surge in Korsakov in the southern part of the Sakhalin Island on November 15, 2019 and comparison of the results of its numerical simulation with the data of in situ measurements constitute the aim of the article.
Development of a Reconstructed Cornea from Collagen-Chondroitin Sulfate Foams and Human Cell Cultures Vrana, N. Engin; Builles, Nicolas; Justin, Virginie; Bednarz, Jurgen; Pellegrini, Graziella; Ferrari, Barbara; Damour, Odile; Hulmes, David J. S.; Hasırcı, Vasıf Nejat (2008-12-01) PURPOSE. To develop an artificial cornea, the ability to coculture the different cell types present in the cornea is essential. Here the goal was to develop a full-thickness artificial cornea using an optimized collagen-chondroitin sulfate foam, with a thickness close to that of human cornea, by coculturing human corneal epithelial and stromal cells and transfected human endothelial cells.
Determining and Evaluating Ideal Physics Teacher s Characteristics Eryılmaz, Ali (Hacettepe Üniversitesi Eğitim Fakültesi, 1999-01-01) The main purpose of this studyare; to investigate the characteristics of a prospective physics teacher, to evaluate attitudesof preservice physics teachers toward to be a physics teacher, and to evaluate preservice physics teachers' qualifications. In order to achieve the objectives of the study, literature have been searched in detail. Then, a questionnaire was developed to measure preservice physics teachers qualifications and attimdes of preservice physics teachers toward to be a physics teacher. The Que...
Reanalysis of high-resolution XMM-Newton data of V2491 Cygni using models of collisionally ionized hot absorbers Balman, Şölen; Gamsizkan, C. (2017-02-01) Aims. We model spectral absorption features in data of the high-resolution XMM-Newton Reflection Grating Spectrometer.

Citation Formats

M. D. Kars, O. D. Iseri, and U. Gündüz, “Drug resistant breast cancer cells overexpress ETS1 gene,” BIOMEDICINE & PHARMACOTHERAPY, pp. 458–462, 2010, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/30079.